Gisadenafil

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameGisadenafil
Drug Alias Name吉沙那非gisadenafilogisadenafilumUK-369003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 5A inhibitors
TargetsPhosphodiesterase 5A
Therapy Area/IndicationsUrinary Bladder, OveractiveErectile DysfunctionProstatic Hyperplasia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[25] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, OveractiveErectile DysfunctionProstatic Hyperplasia +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG